Physician profile
Neil Suryadevara
NPI 1790217370
$8,755.92
in general payments reported to CMS, 2019-2025
12 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $94.16 · 2023: $2,762 · 2024: $5,671 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,450 · Food and Beverage: $2,208 · Gift: $3.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,449.85 |
| Food and Beverage | $2,208.06 |
| Gift | $3.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,535.92 | 2023-2024 | Penumbra System, Red 72, Benchmark |
| Stryker Corporation | $2,265.38 | 2023-2024 | Target, Trevo, Neuroform Ez 3 |
| Balt USA, LLC | $2,184.33 | 2023-2024 | Eclipse 2l, Optima Coil System, Raptor Aspiration Catheter |
| Medical Device Business Services, INC. | $903.85 | 2024 | Trufill, Pulsar Vascular Pulserider Aneurysm Neck Reconstruction Device, Embotrap |
| Microvention, INC. | $249.28 | 2022-2025 | Web Aneurysm Embolization System, Stent, Chaperon Guiding Catheter |
| Abbvie INC. | $224.96 | 2023-2025 | Ubrelvy |
| Medtronic, INC. | $157.56 | 2023 | Linq II |
| Depuy Synthes Sales INC. | $95.24 | 2023-2024 | Trufill, Embotrap, Emboguard |
| Amgen INC. | $57.55 | 2023 | Repatha |
| Ipsen Biopharmaceuticals, INC | $32.39 | 2025 | Dysport |
| Route 92 Medical, INC. | $29.13 | 2025 | |
| Imperative Care, INC | $20.33 | 2023 | Zoom Rdl Radial Access System, 103cm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Suryadevara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.